Douglas Howell
Analyst · Barclays
Thanks, Pat, and good morning, everyone. Thanks for jumping on to this. It's terrific to have a great start to the year with a great quarter and obviously, we've been busy on the M&A front. And so I'm going to clip my comments a little shorter on the press release today so that we can spend some more time on Wesfarmers and the overall transaction.
First of all, in the face of the press release, a couple of things. There's nothing on the face that I would say is unexpected. You see the normal adjustments for bookings, our integration costs, workforce termination and acquisition-related adjustments. But overall, on the adjusted basis, the Brokerage business had an excellent quarter, being up 34% EBITDA and 32% in EPS.
In the Risk Management segment, a nice quarter, solid, organic growth. And in this, recall that we picked up a claim portfolio transfer with a large insurance carrier that recognized our capabilities. That's coming through our accounts nicely. That is excluded from organic growth. So as you look at the organic growth for the Risk Management segment, it reported 6%, but there's about $2.5 million that came from that book transfer. We refer to that as an acquisition. That would have fueled organic growth. You look at that element of this by another 1.5 points.
When I look at -- when I flip to the second page and I look at the organic growth, I want to make a couple of comments on base commissions and fees. A couple of things, in the 3.3% organic on just the base commissions and fees, the U.S. business was around that 3%, probably a little bit above it. Our international was slightly below it. If you look at wholesale versus retail, retail outperformed wholesale a little bit, but by and large, all of it in that solid 3%-plus range.
Also noteworthy, because this is seasonally our smallest quarter, I encourage you to take a look at our investor supplement that we post on the website and when you go back over the last 20 quarters, you'll see that in each of the last 5 years, our first quarter organic growth rate lags what you see in the next 3 quarters. So I think in every single case, our first quarter organic growth, and this is natural. In our environment, our people press pretty hard to push towards getting accounts up and running by the end of the year, just the way the natural tendency is. And so because we're seasonal, I don't know if it was the chicken or the egg, we just have a pattern of reporting slightly less, maybe 1 point less of organic growth in the first quarter than we do in subsequent quarters. So I don't see -- things, certainly, can change going forward, but I see that as a pattern that's noteworthy of looking at it.
As I look through it, we didn't have a lot of nonrecurring wins. We did have one market that lost its rating right in the middle of a renewal that may have put a slight damper -- maybe 20 basis points in terms of organic, but by and large, nothing stands out in terms of organic on that.
When you look at rates and exposure, we're still less than 1% coming from rate and exposure. This is an environment where just new business is outpacing loss business. And I would say that that's consistent with what we've been saying for the last, really, 8 or 9 quarters.
Staying on Page 2, but moving down onto supplementals and contingents, a tremendous quarter. And really, I think that when you look at the supplemental and contingent line, this is an industry -- indicator of, really, the health of the insurance industry. I think it shows the continued growth that Gallagher has. We're growing with our good -- with our carrier partners and the book of business that we're growing is profitable, so I think that this is nice recognition of the work that Gallagher is doing in order to grow our business with our -- with the insurance carriers.
When we move down to the compensation ratio on Brokerage, you'll see that we improved there. This is good discipline on harvesting some of our productivity gains. So you're seeing an improvement in the compensation ratio there, so that's good work to the team. And nothing stands out on the operating expense ratio, translates on the top of Page 3 into nice margin expansion for the Brokerage segment. Obviously, the roll-in of Giles and Bollinger did help that a little bit, but probably 1/2 of that growth was related to them coming in at just naturally higher margins and the other was just the fact that we improved margins on our -- on the rest of our book of business, so up -- being up 150 basis points probably split between acquisition roll-in and just natural expansion. Obviously, we'll get back to acquisitions in a bit.
I want to move to Risk Management. We talk about the book transfer. Good solid organic growth, coming both domestically and international there. I had an opportunity to spend time down in Australia, obviously, over the last couple of weeks. And I just have to tell you, what's going on in our Australia operations down there and bringing self-insurance in and -- to the work cover schemes into commercial carriers down there continues to be a nice, nice win for Gallagher. And I think that will be a nice complementary aspect of what we're doing with the Wesfarmers group.
The comp ratio, nothing stands out. It's up a little bit, but you see that sometimes in our first quarter because of the way we give raises. The operating expense ratio continues to show that we get better as we do things. But overall, to be up over 16%, I'm on the next page now, it's a nice recovery. If you recall in the fourth quarter, we were slightly below 16% because we got hit by a couple employee-related severe medical claims. It's nice to see this unit rebound and be well up over their 16-point target for the quarter.
Turning to Corporate segment. Corporate segment had a solid, solid quarter in clean energy. You'll note in there that we executed a transaction that triggered about a $14 million after-tax gain. What that is, is that we have -- we purchased back portions of plants that we had previously sold off at a substantial discount. We did sell because our growth and appetite for tax credits is growing. Our partner that was in those plants, a tremendous part of their appetite for tax credits was decreasing because of their tax position, so we saw this as an excellent opportunity to take those portions of plants back. Of course, the interplay with that is when you get a chance, you go through our supplement and you look at what's happened with our outlook for the rest of the year. You'll see not only has it gone up by this $14 million gain, but because we now have these plants and the continued rollout of the plant, we've actually upped our guidance and outlook for the Corporate segment clean energy investment. So a really solid quarter and good work to the team there.
I think also a noteworthy item is our income tax rate in the Brokerage and Risk Management segments continues to migrate lower that on a standalone basis, and that's because of the mix of our international business in lower taxed jurisdictions. So you'll see that our tax rate, when you do the math, came down a couple of points in the quarter but that's through economic difference between earnings in foreign jurisdictions at a lower tax rate than in the U.S. So that's -- as we continue to expand internationally, that's good work.
All right. So I'm going to leave the press release now and let me jump into the acquisition of Wesfarmers. First and foremost, we think this is, in fact, a tremendous fit for us. Two really, really, nice units there in New Zealand and Australia, and a nice little bolt-on piece in the U.K. All of them are running nice margins and it's an accretive deal for us. We're excited about that and we think that the opportunity to join forces with them, the spread of mix of business is nice medium, medium-sized accounts, feels a lot like us, good 20 to 30 branches in Australia, 20 to 30 branches in New Zealand, while next to no market share in Australia. We've got a nice market share in New Zealand. But in both places, we see an opportunity for a relationship together as being able to grow that business.
We know that business down there. We have a nice organization run down there on the Brokerage side that's got $30 million to $50 million of revenue in Australia. So we do understand that business, but the fact is that we're not going to trip up over one another. There's going to be very little integration that goes on down in Australia and New Zealand, other than maybe trying to system share, rent share with some of our locations and with the Gallagher Bassett operations that are already 1,000 folks strong down in Australia. So we will be able to pick up some back office efficiency. The critical mass that we get out of that business down there really allows us to save some money.
The other thing, too, is it presents a ripe opportunity for us to continue the bolt-on acquisitions down there. We are seeing lots of brokers that have an interest in joining Gallagher. We picked up a nice new merger partner in New Zealand, coincidentally, last week. The Gallagher story sells well down there, and I think now having the Crombie Lockwood and the OAMPS folks on-board to tell a combined story, I think we've got a good place.
In terms of the organization itself, Wesfarmers did a great job of making this a well-controlled and financially-disciplined organization. I think that, that fits well with what we are trying to do on the financial side, the budget and planning side, obviously, the control side. So we found a -- that the hard work that Wesfarmers put in to make this a part of a public company should be great for us when it comes to transition on that.
In terms of what it also does for us in terms of market relations, Pat may make some comments on that. The fact is we're getting bigger with our carriers down there and this will really put us in a position to be in good shape with them and then I'll let you talk a little bit more about the trading relationships with London, wholesale operations, et cetera.
So overall, on the financial side, one of the things to think about, let me go back and make sure that -- we filed an acquisition set of slides on the Internet on our website. If you have a chance to take a look at those, I really would encourage you to read through the points in there, obviously. But there's a couple of things that I'd like you to look at. Page 8 of that, most notably is the valuation. And if you don't have it in front of you, if you look at this deal, we're paying USD 933 million for it. It'll come with net assets of about $45 million, $46 million, so it will be an $887 million U.S. transaction. We think with synergies, this business will be at somewhere around 80 -- excuse me, $98 million to $99 million of EBITDAC. So that puts it out on a multiple, for us, of about 9.0.
There's also an important footnote on Page 8 that I'd like you to make sure you take a look at because of -- if you look at the tax rate in Australia being $0.30 -- 30%, we intend to, in some part, repatriate those earnings to the U.S., not in all, but some parts of that. And as a result of that, we think that the effective tax rate for the organization could be south of 20%. We did this for illustrative purposes on Page 8. And if you take that into consideration, it brings our multiple down to about 7.8x EBITDAC. So we believe that's a very, very fair multiple. It's a great sale for Wesfarmers and it's a great buy for us. It really is a win-win situation, a lot to do because of the synergies that we can get and then also because of the tax rates that -- differential that we can bring to bear.
The other thing, elsewhere in the document back on Page 10, we give you a computation of accretion on this deal, under the hypothetical amount of shares that we would use in a mix of using cash on hand, 2.25x debt in the structure and the remainder in share issuances. It shows, and you can look at this, whether you want to use, integration, non-integration, reported versus adjusted, but it's anywhere from $0.09 to $0.17 accretive.
And there's also an important footnote on Page 10. Those numbers do not factor in the additional tax benefit that we will get by being able to keep more of our credit, which could produce additional accretion of $0.07 to $0.10 per share. So on a bid/ask spread difference, you could have it anywhere from $0.09 all the way up to maybe as much as $0.27 accretive on this deal, depending on how you choose to look at it. We believe the ability to have a lesser tax rate is important for Gallagher, but just even on just a standalone basis, it looks like it's nicely accretive there.
I think those are my comments, financially. I think that in this deck, maybe we'll flip through a few more pages. Pat, why don't we move back to some more strategic rationale for doing the deal, and then we'll open it up for Q&A, right?